1-(4-Methoxyphenyl)-2-phenylethanone>98.0%(GC)5g

N-(2-Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid Hydrate (HEPPSO), 99.0%, 5g

(S)-1-(5-Bromopyridin-3-yl)ethan-1-ol, 98%, 100mg

tert-Butyl ({5-[5-(trifluoromethyl)pyridin-2-yl]-1,2,4-oxadiazol-3-yl}methyl)carbamate, 95.0%, 1g

(2,6-Difluoropyridin-4-yl)boronic acid, 95.0%, 10g

(R)-2-AMINO-3-(TETRAHYDRO-2H-PYRAN-4-YL)PROPANOIC ACID HYDROCHLORIDE, 95.0%, 100mg

7-Chloro-6-nitroquinazolin-4(3H)-one, 95.0%, 100g

Piperazine, 1-(6-bromo-3-pyridinyl)-, 95.0%, 25g

Obiettivo PLPOLi 40x/0,65 IOS pianificato senza deformazioni per polarizzazione trasmessa iScope, correzione del vetro di copertura da 0,17 mm. Distanza di lavoro 0,54 mm

tert-Butyl 4-((trimethylsilyl)ethynyl)benzoate, 95.0%, 250mg

(2E)-3-(2-hydroxyphenyl)acrylic acid, 98.0%, 5g

(R)-3-Hydroxy-1-methyl-pyrrolidine, 98.0%, 25g

[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl]amine, 95.0%, 250mg